Official Website

Eduardo Krulig
English
Español
Scientific Publications
About Dr. Eduardo Krulig
Clinical Cases
NewMelan: What to Expect
The Before and After
NewMelan Blog
International Events
Eduardo Krulig
English
Español
Scientific Publications
About Dr. Eduardo Krulig
Clinical Cases
NewMelan: What to Expect
The Before and After
NewMelan Blog
International Events
Más
  • English
  • Español
  • Scientific Publications
  • About Dr. Eduardo Krulig
  • Clinical Cases
  • NewMelan: What to Expect
  • The Before and After
  • NewMelan Blog
  • International Events
  • English
  • Español
  • Scientific Publications
  • About Dr. Eduardo Krulig
  • Clinical Cases
  • NewMelan: What to Expect
  • The Before and After
  • NewMelan Blog
  • International Events

Scientific Publications


RESEARCH • SCIENCE • EVIDENCE

In this section, you will find peer-reviewed scientific publications, clinical case reports, and other academic works related to the management of pigmentary disorders using the NewMelan® Depigmentation Protocol. 

Each publication contributes to expanding the available evidence and reflects NewMelan®'s commitment to research, clinical practice, and evidence-based medicine.  

Available Articles

July 2026

Diffuse Facial Melasma and Lentigines Treated with the NewMelan Multimodal Depigmentation Protocol

This case report describes the clinical course of a 75-year-old patient with diffuse facial melasma and lentigines treated using the NewMelan® Depigmentation Protocol, developed by Dr. Eduardo Krulig. The publication documents visible improvement in hyperpigmentation and overall skin tone uniformity during the first weeks of treatment, with no adverse events reported during the observation period. As is customary in this type of publication, the authors emphasize the need for larger studies and long-term follow-up to confirm these findings and evaluate their clinical reproducibility. 

📖JOURNAL: CUREUS

Publication Type: Case Report
Language: English
Access: Open Access
Publisher: Springer Nature
DOI: 10.7759/cureus.112167 

🔗 Read on Cureus
Download PDF

July 2026

Treatment of Refractory Centrofacial Melasma in a 64-Year-Old Female

This case report describes the clinical course of a 64-year-old female patient with refractory centrofacial melasma treated using the NewMelan® Depigmentation Protocol. The publication documents a progressive and visible reduction in facial hyperpigmentation during the first weeks of treatment following the failure of multiple conventional therapies, including chemical peels, mechanical peels, and laser-based treatments. A significant improvement in cosmetic appearance was also observed, accompanied by a high level of patient satisfaction. As is customary with case reports, the authors emphasize the need for larger clinical studies and longer-term follow-up to confirm these findings and further evaluate the efficacy, safety, and durability of the observed outcomes. 

📖JOURNAL: CUREUS

Publication Type: Case Report
Language: English
Access: Open Access
Publisher: Springer Nature
DOI: 10.7759/cureus.112676 

🔗 Read on Cureus
Download PDF

Ongoing Research

The generation of scientific evidence is an ongoing process. The NewMelan® Scientific Team is currently working on new publications aimed at expanding clinical knowledge on the management of pigmentary disorders through the use of the NewMelan® Depigmentation Protocol.


Current research topics include:

  • Melasma
  • Post-Inflammatory Hyperpigmentation (PIH)
  • Body Hyperpigmentation
  • Hyperpigmentation of Intimate Areas
  • Solar Lentigines
  • Photoaging-Associated Dyschromia

Copyright © 2026 Eduardo Krulig - Todos los derechos reservados.

Con tecnología de

  • English
  • Español
  • Clinical Cases
  • The Before and After
  • International Events
  • Private Policy
  • Cookie Policy
  • CCPA Do Not Sell My Data

Este sitio web utiliza cookies

 We use our own and third-party cookies to enhance your browsing experience, personalize content and ads, and analyze traffic on our website. You can accept all cookies or reject them. For more details, please see our Cookie Policy. 

RejectAccept